Related Experiment Video
Updated: Jun 8, 2025

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches
1Washington University Saint Louis, Neuromuscular Disease Center, 660 S. Euclid Ave., St Louis, MO 63110, USA.
Abstract:
Treatments for disabling and life-threatening hereditary muscle disorders are finally close to becoming a reality. Research has thus far focused primarily on recessive forms of muscle disease. The gene replacement strategies that are commonly employed for recessive, loss-of-function disorders are not readily translatable to most dominant myopathies owing to the presence of a normal chromosome in each nucleus, hindering the development of novel treatments for these dominant disorders. This is largely due to their complex, heterogeneous disease mechanisms that require unique therapeutic approaches. However, as viral and RNA interference-based therapies enter clinical use, key tools are now in place to develop treatments for dominantly inherited disorders of muscle. This article will review what is known about dominantly inherited disorders of muscle, specifically their genetic basis, how mutations lead to disease, and the pathomechanistic implications for therapeutic approaches.
Insights
Gene therapies for dominant myopathies are emerging. New tools like viral and RNA interference therapies offer hope for treating these complex genetic muscle disorders.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Hereditary muscle disorders, particularly dominant myopathies, present significant therapeutic challenges.
- Current research predominantly targets recessive muscle diseases, leaving dominant forms with fewer treatment options.
- The complex and heterogeneous mechanisms of dominant myopathies necessitate specialized therapeutic strategies.
Purpose of the Study:
- To review the current understanding of dominantly inherited muscle disorders.
- To explore the genetic basis and mutation-induced disease mechanisms.
- To discuss pathomechanistic implications for developing novel therapeutic approaches.
Main Methods:
- Review of existing literature on dominant myopathies.
- Analysis of genetic underpinnings and molecular pathology.
- Examination of emerging therapeutic technologies.
Main Results:
- Dominant myopathies possess complex genetic and molecular mechanisms.
- Traditional gene replacement is often unsuitable for dominant disorders.
- Advancements in viral and RNA interference therapies are enabling new treatment avenues.
Conclusions:
- Effective treatments for dominant myopathies are becoming feasible.
- Understanding disease mechanisms is crucial for targeted therapy development.
- Emerging technologies hold promise for addressing these debilitating conditions.
Related Concept Videos
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Satellite Stem Cells and Muscular Dystrophy
Sex-linked Disorders
Parkinson's Disease: Overview

